nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Thiotepa—sarcoma	0.35	0.458	CbGbCtD
Fosamprenavir—CYP3A4—Mitoxantrone—sarcoma	0.151	0.197	CbGbCtD
Fosamprenavir—CYP3A4—Vincristine—sarcoma	0.104	0.136	CbGbCtD
Fosamprenavir—CYP3A4—Etoposide—sarcoma	0.095	0.124	CbGbCtD
Fosamprenavir—CYP3A4—Doxorubicin—sarcoma	0.0648	0.0848	CbGbCtD
Fosamprenavir—Drug hypersensitivity—Epirubicin—sarcoma	0.00379	0.0161	CcSEcCtD
Fosamprenavir—Opportunistic infection—Epirubicin—sarcoma	0.00379	0.0161	CcSEcCtD
Fosamprenavir—Drug hypersensitivity—Doxorubicin—sarcoma	0.00351	0.0149	CcSEcCtD
Fosamprenavir—Opportunistic infection—Doxorubicin—sarcoma	0.00351	0.0149	CcSEcCtD
Fosamprenavir—Myositis—Epirubicin—sarcoma	0.00311	0.0132	CcSEcCtD
Fosamprenavir—Myositis—Doxorubicin—sarcoma	0.00288	0.0122	CcSEcCtD
Fosamprenavir—Inflammation—Etoposide—sarcoma	0.00281	0.0119	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00248	0.0105	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00246	0.0104	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00243	0.0103	CcSEcCtD
Fosamprenavir—Neutropenia—Dactinomycin—sarcoma	0.00221	0.00936	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Vincristine—sarcoma	0.0022	0.00932	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Thiotepa—sarcoma	0.00215	0.0091	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.00214	0.00908	CcSEcCtD
Fosamprenavir—Hyperlipidaemia—Epirubicin—sarcoma	0.00212	0.00898	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.0021	0.00889	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00209	0.00885	CcSEcCtD
Fosamprenavir—Neutropenia—Vincristine—sarcoma	0.00197	0.00837	CcSEcCtD
Fosamprenavir—Hyperlipidaemia—Doxorubicin—sarcoma	0.00196	0.00831	CcSEcCtD
Fosamprenavir—Neutropenia—Mitoxantrone—sarcoma	0.00192	0.00815	CcSEcCtD
Fosamprenavir—Haemoglobin—Thiotepa—sarcoma	0.00191	0.00812	CcSEcCtD
Fosamprenavir—Haemorrhage—Thiotepa—sarcoma	0.0019	0.00808	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Thiotepa—sarcoma	0.00188	0.00798	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Thiotepa—sarcoma	0.00187	0.00794	CcSEcCtD
Fosamprenavir—Urethral disorder—Thiotepa—sarcoma	0.00187	0.00792	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Vincristine—sarcoma	0.00185	0.00786	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Mitoxantrone—sarcoma	0.00185	0.00786	CcSEcCtD
Fosamprenavir—Myocardial infarction—Vincristine—sarcoma	0.00184	0.00782	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00181	0.00766	CcSEcCtD
Fosamprenavir—Myocardial infarction—Mitoxantrone—sarcoma	0.0018	0.00762	CcSEcCtD
Fosamprenavir—Erythema multiforme—Dactinomycin—sarcoma	0.00179	0.00758	CcSEcCtD
Fosamprenavir—Cardiac disorder—Thiotepa—sarcoma	0.00177	0.0075	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Etoposide—sarcoma	0.00174	0.0074	CcSEcCtD
Fosamprenavir—Immune system disorder—Thiotepa—sarcoma	0.00172	0.0073	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Vincristine—sarcoma	0.00167	0.00707	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Vincristine—sarcoma	0.00166	0.00704	CcSEcCtD
Fosamprenavir—Malnutrition—Thiotepa—sarcoma	0.00166	0.00703	CcSEcCtD
Fosamprenavir—Urethral disorder—Vincristine—sarcoma	0.00166	0.00702	CcSEcCtD
Fosamprenavir—Haemoglobin—Mitoxantrone—sarcoma	0.00165	0.00701	CcSEcCtD
Fosamprenavir—Haemorrhage—Mitoxantrone—sarcoma	0.00164	0.00697	CcSEcCtD
Fosamprenavir—Neutropenia—Etoposide—sarcoma	0.0016	0.00678	CcSEcCtD
Fosamprenavir—Inflammation—Epirubicin—sarcoma	0.00157	0.00668	CcSEcCtD
Fosamprenavir—Cardiac disorder—Vincristine—sarcoma	0.00157	0.00665	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00151	0.00641	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Etoposide—sarcoma	0.0015	0.00637	CcSEcCtD
Fosamprenavir—Myocardial infarction—Etoposide—sarcoma	0.00149	0.00634	CcSEcCtD
Fosamprenavir—Inflammation—Doxorubicin—sarcoma	0.00146	0.00618	CcSEcCtD
Fosamprenavir—Myalgia—Thiotepa—sarcoma	0.00141	0.00599	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.0014	0.00594	CcSEcCtD
Fosamprenavir—Myalgia—Dactinomycin—sarcoma	0.0014	0.00594	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Etoposide—sarcoma	0.00135	0.00573	CcSEcCtD
Fosamprenavir—Urethral disorder—Etoposide—sarcoma	0.00134	0.00569	CcSEcCtD
Fosamprenavir—Nervous system disorder—Thiotepa—sarcoma	0.00133	0.00563	CcSEcCtD
Fosamprenavir—Skin disorder—Thiotepa—sarcoma	0.00131	0.00557	CcSEcCtD
Fosamprenavir—Erythema multiforme—Etoposide—sarcoma	0.00129	0.00549	CcSEcCtD
Fosamprenavir—Anorexia—Thiotepa—sarcoma	0.00129	0.00547	CcSEcCtD
Fosamprenavir—Anorexia—Dactinomycin—sarcoma	0.00128	0.00543	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Epirubicin—sarcoma	0.00127	0.0054	CcSEcCtD
Fosamprenavir—Cardiac disorder—Etoposide—sarcoma	0.00127	0.00538	CcSEcCtD
Fosamprenavir—Myalgia—Vincristine—sarcoma	0.00125	0.00531	CcSEcCtD
Fosamprenavir—Immune system disorder—Etoposide—sarcoma	0.00124	0.00524	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00123	0.00523	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00122	0.00519	CcSEcCtD
Fosamprenavir—Myalgia—Mitoxantrone—sarcoma	0.00122	0.00517	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Doxorubicin—sarcoma	0.00118	0.005	CcSEcCtD
Fosamprenavir—Nervous system disorder—Vincristine—sarcoma	0.00118	0.00499	CcSEcCtD
Fosamprenavir—Decreased appetite—Thiotepa—sarcoma	0.00118	0.00499	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Thiotepa—sarcoma	0.00117	0.00495	CcSEcCtD
Fosamprenavir—Decreased appetite—Dactinomycin—sarcoma	0.00117	0.00495	CcSEcCtD
Fosamprenavir—Fatigue—Thiotepa—sarcoma	0.00117	0.00495	CcSEcCtD
Fosamprenavir—Fatigue—Dactinomycin—sarcoma	0.00116	0.00491	CcSEcCtD
Fosamprenavir—Anorexia—Vincristine—sarcoma	0.00114	0.00485	CcSEcCtD
Fosamprenavir—Skin disorder—Mitoxantrone—sarcoma	0.00114	0.00481	CcSEcCtD
Fosamprenavir—Anorexia—Mitoxantrone—sarcoma	0.00111	0.00472	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Thiotepa—sarcoma	0.00111	0.00469	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dactinomycin—sarcoma	0.0011	0.00466	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Vincristine—sarcoma	0.00109	0.00464	CcSEcCtD
Fosamprenavir—Abdominal pain—Thiotepa—sarcoma	0.00107	0.00454	CcSEcCtD
Fosamprenavir—Body temperature increased—Thiotepa—sarcoma	0.00107	0.00454	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00106	0.00451	CcSEcCtD
Fosamprenavir—Abdominal pain—Dactinomycin—sarcoma	0.00106	0.0045	CcSEcCtD
Fosamprenavir—Body temperature increased—Dactinomycin—sarcoma	0.00106	0.0045	CcSEcCtD
Fosamprenavir—Decreased appetite—Vincristine—sarcoma	0.00104	0.00442	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Vincristine—sarcoma	0.00104	0.00439	CcSEcCtD
Fosamprenavir—Fatigue—Vincristine—sarcoma	0.00103	0.00439	CcSEcCtD
Fosamprenavir—Decreased appetite—Mitoxantrone—sarcoma	0.00102	0.00431	CcSEcCtD
Fosamprenavir—Fatigue—Mitoxantrone—sarcoma	0.00101	0.00427	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00101	0.00427	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000998	0.00423	CcSEcCtD
Fosamprenavir—Hypersensitivity—Thiotepa—sarcoma	0.000997	0.00423	CcSEcCtD
Fosamprenavir—Hypersensitivity—Dactinomycin—sarcoma	0.000989	0.0042	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vincristine—sarcoma	0.000981	0.00416	CcSEcCtD
Fosamprenavir—Gastritis—Epirubicin—sarcoma	0.000981	0.00416	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000978	0.00415	CcSEcCtD
Fosamprenavir—Asthenia—Thiotepa—sarcoma	0.000971	0.00412	CcSEcCtD
Fosamprenavir—Asthenia—Dactinomycin—sarcoma	0.000964	0.00409	CcSEcCtD
Fosamprenavir—Pruritus—Thiotepa—sarcoma	0.000957	0.00406	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000956	0.00405	CcSEcCtD
Fosamprenavir—Abdominal pain—Vincristine—sarcoma	0.000949	0.00402	CcSEcCtD
Fosamprenavir—Body temperature increased—Vincristine—sarcoma	0.000949	0.00402	CcSEcCtD
Fosamprenavir—Skin disorder—Etoposide—sarcoma	0.000944	0.004	CcSEcCtD
Fosamprenavir—Anorexia—Etoposide—sarcoma	0.000927	0.00393	CcSEcCtD
Fosamprenavir—Diarrhoea—Thiotepa—sarcoma	0.000926	0.00393	CcSEcCtD
Fosamprenavir—Body temperature increased—Mitoxantrone—sarcoma	0.000924	0.00392	CcSEcCtD
Fosamprenavir—Abdominal pain—Mitoxantrone—sarcoma	0.000924	0.00392	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000924	0.00392	CcSEcCtD
Fosamprenavir—Diarrhoea—Dactinomycin—sarcoma	0.000919	0.0039	CcSEcCtD
Fosamprenavir—Gastritis—Doxorubicin—sarcoma	0.000908	0.00385	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000905	0.00384	CcSEcCtD
Fosamprenavir—Neutropenia—Epirubicin—sarcoma	0.000896	0.0038	CcSEcCtD
Fosamprenavir—Dizziness—Thiotepa—sarcoma	0.000895	0.00379	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vincristine—sarcoma	0.000884	0.00375	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Epirubicin—sarcoma	0.000864	0.00367	CcSEcCtD
Fosamprenavir—Hypersensitivity—Mitoxantrone—sarcoma	0.000861	0.00365	CcSEcCtD
Fosamprenavir—Asthenia—Vincristine—sarcoma	0.000861	0.00365	CcSEcCtD
Fosamprenavir—Vomiting—Thiotepa—sarcoma	0.00086	0.00365	CcSEcCtD
Fosamprenavir—Vomiting—Dactinomycin—sarcoma	0.000854	0.00362	CcSEcCtD
Fosamprenavir—Rash—Thiotepa—sarcoma	0.000853	0.00362	CcSEcCtD
Fosamprenavir—Dermatitis—Thiotepa—sarcoma	0.000852	0.00361	CcSEcCtD
Fosamprenavir—Headache—Thiotepa—sarcoma	0.000848	0.00359	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000847	0.00359	CcSEcCtD
Fosamprenavir—Rash—Dactinomycin—sarcoma	0.000847	0.00359	CcSEcCtD
Fosamprenavir—Decreased appetite—Etoposide—sarcoma	0.000845	0.00358	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Etoposide—sarcoma	0.000839	0.00356	CcSEcCtD
Fosamprenavir—Asthenia—Mitoxantrone—sarcoma	0.000838	0.00356	CcSEcCtD
Fosamprenavir—Fatigue—Etoposide—sarcoma	0.000838	0.00355	CcSEcCtD
Fosamprenavir—Neutropenia—Doxorubicin—sarcoma	0.000829	0.00352	CcSEcCtD
Fosamprenavir—Diarrhoea—Vincristine—sarcoma	0.000821	0.00348	CcSEcCtD
Fosamprenavir—Nausea—Thiotepa—sarcoma	0.000804	0.00341	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Doxorubicin—sarcoma	0.0008	0.00339	CcSEcCtD
Fosamprenavir—Diarrhoea—Mitoxantrone—sarcoma	0.0008	0.00339	CcSEcCtD
Fosamprenavir—Nausea—Dactinomycin—sarcoma	0.000798	0.00338	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Etoposide—sarcoma	0.000795	0.00337	CcSEcCtD
Fosamprenavir—Dizziness—Vincristine—sarcoma	0.000793	0.00336	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000784	0.00332	CcSEcCtD
Fosamprenavir—Haemoglobin—Epirubicin—sarcoma	0.000771	0.00327	CcSEcCtD
Fosamprenavir—Abdominal pain—Etoposide—sarcoma	0.000768	0.00326	CcSEcCtD
Fosamprenavir—Body temperature increased—Etoposide—sarcoma	0.000768	0.00326	CcSEcCtD
Fosamprenavir—Haemorrhage—Epirubicin—sarcoma	0.000767	0.00325	CcSEcCtD
Fosamprenavir—Vomiting—Vincristine—sarcoma	0.000763	0.00324	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Epirubicin—sarcoma	0.000757	0.00321	CcSEcCtD
Fosamprenavir—Rash—Vincristine—sarcoma	0.000757	0.00321	CcSEcCtD
Fosamprenavir—Dermatitis—Vincristine—sarcoma	0.000756	0.00321	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Epirubicin—sarcoma	0.000754	0.0032	CcSEcCtD
Fosamprenavir—Urethral disorder—Epirubicin—sarcoma	0.000752	0.00319	CcSEcCtD
Fosamprenavir—Headache—Vincristine—sarcoma	0.000752	0.00319	CcSEcCtD
Fosamprenavir—Vomiting—Mitoxantrone—sarcoma	0.000743	0.00315	CcSEcCtD
Fosamprenavir—Rash—Mitoxantrone—sarcoma	0.000737	0.00312	CcSEcCtD
Fosamprenavir—Dermatitis—Mitoxantrone—sarcoma	0.000736	0.00312	CcSEcCtD
Fosamprenavir—Headache—Mitoxantrone—sarcoma	0.000732	0.0031	CcSEcCtD
Fosamprenavir—Erythema multiforme—Epirubicin—sarcoma	0.000725	0.00307	CcSEcCtD
Fosamprenavir—Hypersensitivity—Etoposide—sarcoma	0.000716	0.00304	CcSEcCtD
Fosamprenavir—Haemoglobin—Doxorubicin—sarcoma	0.000713	0.00302	CcSEcCtD
Fosamprenavir—Nausea—Vincristine—sarcoma	0.000713	0.00302	CcSEcCtD
Fosamprenavir—Cardiac disorder—Epirubicin—sarcoma	0.000712	0.00302	CcSEcCtD
Fosamprenavir—Haemorrhage—Doxorubicin—sarcoma	0.00071	0.00301	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Doxorubicin—sarcoma	0.000701	0.00297	CcSEcCtD
Fosamprenavir—Asthenia—Etoposide—sarcoma	0.000697	0.00296	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Doxorubicin—sarcoma	0.000697	0.00296	CcSEcCtD
Fosamprenavir—Urethral disorder—Doxorubicin—sarcoma	0.000696	0.00295	CcSEcCtD
Fosamprenavir—Nausea—Mitoxantrone—sarcoma	0.000694	0.00294	CcSEcCtD
Fosamprenavir—Immune system disorder—Epirubicin—sarcoma	0.000693	0.00294	CcSEcCtD
Fosamprenavir—Pruritus—Etoposide—sarcoma	0.000688	0.00292	CcSEcCtD
Fosamprenavir—Erythema multiforme—Doxorubicin—sarcoma	0.000671	0.00285	CcSEcCtD
Fosamprenavir—Malnutrition—Epirubicin—sarcoma	0.000668	0.00283	CcSEcCtD
Fosamprenavir—Diarrhoea—Etoposide—sarcoma	0.000665	0.00282	CcSEcCtD
Fosamprenavir—Cardiac disorder—Doxorubicin—sarcoma	0.000659	0.00279	CcSEcCtD
Fosamprenavir—Flatulence—Epirubicin—sarcoma	0.000658	0.00279	CcSEcCtD
Fosamprenavir—Dizziness—Etoposide—sarcoma	0.000643	0.00273	CcSEcCtD
Fosamprenavir—Immune system disorder—Doxorubicin—sarcoma	0.000641	0.00272	CcSEcCtD
Fosamprenavir—Vomiting—Etoposide—sarcoma	0.000618	0.00262	CcSEcCtD
Fosamprenavir—Malnutrition—Doxorubicin—sarcoma	0.000618	0.00262	CcSEcCtD
Fosamprenavir—Rash—Etoposide—sarcoma	0.000613	0.0026	CcSEcCtD
Fosamprenavir—Dermatitis—Etoposide—sarcoma	0.000612	0.0026	CcSEcCtD
Fosamprenavir—Headache—Etoposide—sarcoma	0.000609	0.00258	CcSEcCtD
Fosamprenavir—Flatulence—Doxorubicin—sarcoma	0.000609	0.00258	CcSEcCtD
Fosamprenavir—Nausea—Etoposide—sarcoma	0.000577	0.00245	CcSEcCtD
Fosamprenavir—Myalgia—Epirubicin—sarcoma	0.000568	0.00241	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000564	0.00239	CcSEcCtD
Fosamprenavir—Nervous system disorder—Epirubicin—sarcoma	0.000534	0.00227	CcSEcCtD
Fosamprenavir—Skin disorder—Epirubicin—sarcoma	0.000529	0.00224	CcSEcCtD
Fosamprenavir—Myalgia—Doxorubicin—sarcoma	0.000526	0.00223	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000522	0.00221	CcSEcCtD
Fosamprenavir—Anorexia—Epirubicin—sarcoma	0.000519	0.0022	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000496	0.00211	CcSEcCtD
Fosamprenavir—Nervous system disorder—Doxorubicin—sarcoma	0.000494	0.0021	CcSEcCtD
Fosamprenavir—Skin disorder—Doxorubicin—sarcoma	0.00049	0.00208	CcSEcCtD
Fosamprenavir—Anorexia—Doxorubicin—sarcoma	0.000481	0.00204	CcSEcCtD
Fosamprenavir—Decreased appetite—Epirubicin—sarcoma	0.000474	0.00201	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Epirubicin—sarcoma	0.00047	0.00199	CcSEcCtD
Fosamprenavir—Fatigue—Epirubicin—sarcoma	0.00047	0.00199	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000459	0.00195	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Epirubicin—sarcoma	0.000446	0.00189	CcSEcCtD
Fosamprenavir—Decreased appetite—Doxorubicin—sarcoma	0.000438	0.00186	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000435	0.00185	CcSEcCtD
Fosamprenavir—Fatigue—Doxorubicin—sarcoma	0.000435	0.00184	CcSEcCtD
Fosamprenavir—Abdominal pain—Epirubicin—sarcoma	0.000431	0.00183	CcSEcCtD
Fosamprenavir—Body temperature increased—Epirubicin—sarcoma	0.000431	0.00183	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Doxorubicin—sarcoma	0.000412	0.00175	CcSEcCtD
Fosamprenavir—Hypersensitivity—Epirubicin—sarcoma	0.000401	0.0017	CcSEcCtD
Fosamprenavir—Abdominal pain—Doxorubicin—sarcoma	0.000399	0.00169	CcSEcCtD
Fosamprenavir—Body temperature increased—Doxorubicin—sarcoma	0.000399	0.00169	CcSEcCtD
Fosamprenavir—Asthenia—Epirubicin—sarcoma	0.000391	0.00166	CcSEcCtD
Fosamprenavir—Pruritus—Epirubicin—sarcoma	0.000385	0.00163	CcSEcCtD
Fosamprenavir—Diarrhoea—Epirubicin—sarcoma	0.000373	0.00158	CcSEcCtD
Fosamprenavir—Hypersensitivity—Doxorubicin—sarcoma	0.000371	0.00158	CcSEcCtD
Fosamprenavir—Asthenia—Doxorubicin—sarcoma	0.000362	0.00153	CcSEcCtD
Fosamprenavir—Dizziness—Epirubicin—sarcoma	0.00036	0.00153	CcSEcCtD
Fosamprenavir—Pruritus—Doxorubicin—sarcoma	0.000357	0.00151	CcSEcCtD
Fosamprenavir—Vomiting—Epirubicin—sarcoma	0.000346	0.00147	CcSEcCtD
Fosamprenavir—Diarrhoea—Doxorubicin—sarcoma	0.000345	0.00146	CcSEcCtD
Fosamprenavir—Rash—Epirubicin—sarcoma	0.000344	0.00146	CcSEcCtD
Fosamprenavir—Dermatitis—Epirubicin—sarcoma	0.000343	0.00146	CcSEcCtD
Fosamprenavir—Headache—Epirubicin—sarcoma	0.000341	0.00145	CcSEcCtD
Fosamprenavir—Dizziness—Doxorubicin—sarcoma	0.000333	0.00141	CcSEcCtD
Fosamprenavir—Nausea—Epirubicin—sarcoma	0.000324	0.00137	CcSEcCtD
Fosamprenavir—Vomiting—Doxorubicin—sarcoma	0.000321	0.00136	CcSEcCtD
Fosamprenavir—Rash—Doxorubicin—sarcoma	0.000318	0.00135	CcSEcCtD
Fosamprenavir—Dermatitis—Doxorubicin—sarcoma	0.000318	0.00135	CcSEcCtD
Fosamprenavir—Headache—Doxorubicin—sarcoma	0.000316	0.00134	CcSEcCtD
Fosamprenavir—Nausea—Doxorubicin—sarcoma	0.000299	0.00127	CcSEcCtD
